InMed Pharmaceuticals Reports Second Quarter Fiscal 2022 Financial Results and Provides Business Update
15.02.2022 - Completed acquisition of BayMedica, a rare cannabinoid manufacturing and commercialization company in the health and wellness sectorStrengthened IP with patent filing for use of rare cannabinoids for the treatment of neurodegenerative ...